CoChat

Diverse RNA-Binding Proteins Interact with Functionally Related Sets of RNAs, Suggesting an Extensive Regulatory System

Open access
Hogan, Daniel J, Riordan, Daniel P, Gerber, André P, Herschlag, Daniel, Brown, Patrick O · 2008 · PLoS Biology

The DOI matches its Crossref record; 163 of the 164 references it cites were found in a registry or an index.

Abstract

RNA-binding proteins (RBPs) have roles in the regulation of many post-transcriptional steps in gene expression, but relatively few RBPs have been systematically studied. We searched for the RNA targets of 40 proteins in the yeast Saccharomyces cerevisiae: a selective sample of the approximately 600 annotated and predicted RBPs, as well as several proteins not annotated as RBPs. At least 33 of these 40 proteins, including three of the four proteins that were not previously known or predicted to be RBPs, were reproducibly associated with specific sets of a few to several hundred RNAs. Remarkably, many of the RBPs we studied bound mRNAs whose protein products share identifiable functional or cytotopic features. We identified specific sequences or predicted structures significantly enriched in target mRNAs of 16 RBPs. These potential RNA-recognition elements were diverse in sequence, structure, and location: some were found predominantly in 3'-untranslated regions, others in 5'-untranslated regions, some in coding sequences, and many in two or more of these features. Although this study only examined a small fraction of the universe of yeast RBPs, 70% of the mRNA transcriptome had significant associations with at least one of these RBPs, and on average, each distinct yeast mRNA interacted with three of the RBPs, suggesting the potential for a rich, multidimensional network of regulation. These results strongly suggest that combinatorial binding of RBPs to specific recognition elements in mRNAs is a pervasive mechanism for multi-dimensional regulation of their post-transcriptional fate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pbio.0060255

Cites

163 of 163 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Diverse Binding Specificity among RNA-Binding Proteins (A) Estimated number of RNA species (y-axis) associated with each protein in this survey (x-axis) at a 1% FDR threshold. The proportions of bound RNAs in each of several classes are represented by colors: nuclear-encoded mRNAs (black), nuclear introns (red), mitochondrion-encoded mRNAs (green), C/D box snoRNAs (cyan), H/ACA box snoRNAs (magenta), and all other RNAs (grey), which includes ribosomal RNAs, LSR1, NME1, SCR1, SRG1, TLC1, mitochondrial introns, unannotated “intergenic” transcripts (named IGR* and IGX* in Datasets S1–S3), tRNAs, and splice junctions. An asterisk (*) denotes proteins whose targets were identified using DNA microarrays that did not contain probes designed to detect most non-nuclear-encoded mRNAs. Six proteins from our previously published work (Puf1–5 and She2) are also included (marked with a plus sign [+]). (B) Hierarchically clustered heat map representation of RBPs and their RNA targets. Rows correspond to specific RBPs and columns correspond to RNAs. The certainty that the RNA is a bona fide target of the specified RBP is represented by a continuous black (10% FDR or greater) to yellow (0% FDR) scale. (C) The distribution of the number of RBPs bound per mRNA at 1% FDR threshold is shown as a bar plot. The black bars represent the values for the 31 RBPs associated with at least ten mRNAs, and the grey bars represent the 22 RBPs associated with at least ten mRNAs, but fewer than 500 mRNAs.
Figure 1 Diverse Binding Specificity among RNA-Binding Proteins (A) Estimated number of RNA species (y-axis) associated with each protein in this survey (x-axis) at a 1% FDR threshold. The proportions of bound RNAs in each of several classes are represented by colors: nuclear-encoded mRNAs (black), nuclear introns (red), mitochondrion-encoded mRNAs (green), C/D box snoRNAs (cyan), H/ACA box snoRNAs (magenta), and all other RNAs (grey), which includes ribosomal RNAs, LSR1, NME1, SCR1, SRG1, TLC1, mitochondrial introns, unannotated “intergenic” transcripts (named IGR* and IGX* in Datasets S1–S3), tRNAs, and splice junctions. An asterisk (*) denotes proteins whose targets were identified using DNA microarrays that did not contain probes designed to detect most non-nuclear-encoded mRNAs. Six proteins from our previously published work (Puf1–5 and She2) are also included (marked with a plus sign [+]). (B) Hierarchically clustered heat map representation of RBPs and their RNA targets. Rows correspond to specific RBPs and columns correspond to RNAs. The certainty that the RNA is a bona fide target of the specified RBP is represented by a continuous black (10% FDR or greater) to yellow (0% FDR) scale. (C) The distribution of the number of RBPs bound per mRNA at 1% FDR threshold is shown as a bar plot. The black bars represent the values for the 31 RBPs associated with at least ten mRNAs, and the grey bars represent the 22 RBPs associated with at least ten mRNAs, but fewer than 500 mRNAs.CC BY · PubMed Central
Figure 2 RNA-Binding Proteins Bind mRNAs Encoding Functionally and Cytotopically Related Proteins (A) Enrichment of “cellular component” GO terms (rows) in target sets (1% FDR) of RBPs (columns). The significance of enrichment of the GO term is represented as a heat map (scale is to the left of the figure) in which the color intensity corresponds to the negative log10 p-value, calculated using the hypergeometric density distribution function and corrected for multiple hypothesis testing using the Bonferroni method. Only a subset of significantly enriched GO terms are shown. RBPs whose targets are significantly enriched (p ≤ 0.01) for at least one “cellular component” or “biological process” GO term are shown. (B) Same as in (A), except for “biological process” GO terms.
Figure 2 RNA-Binding Proteins Bind mRNAs Encoding Functionally and Cytotopically Related Proteins (A) Enrichment of “cellular component” GO terms (rows) in target sets (1% FDR) of RBPs (columns). The significance of enrichment of the GO term is represented as a heat map (scale is to the left of the figure) in which the color intensity corresponds to the negative log10 p-value, calculated using the hypergeometric density distribution function and corrected for multiple hypothesis testing using the Bonferroni method. Only a subset of significantly enriched GO terms are shown. RBPs whose targets are significantly enriched (p ≤ 0.01) for at least one “cellular component” or “biological process” GO term are shown. (B) Same as in (A), except for “biological process” GO terms.CC BY · PubMed Central
Figure 3 Differential Exon/Intron Association Suggests That Certain RNA-Binding Proteins Bind Their Targets during Specific Stages in Their Lives The relative enrichment of exons and introns in association with RBPs (columns) is represented using a color scale. Results are shown for RBPs that associated substantially more or less strongly with exons or introns than with RNAs overall (mean enrichment of exons from intron-containing genes or introns 25% above or below the median IP enrichment of all RNAs, respectively).
Figure 3 Differential Exon/Intron Association Suggests That Certain RNA-Binding Proteins Bind Their Targets during Specific Stages in Their Lives The relative enrichment of exons and introns in association with RBPs (columns) is represented using a color scale. Results are shown for RBPs that associated substantially more or less strongly with exons or introns than with RNAs overall (mean enrichment of exons from intron-containing genes or introns 25% above or below the median IP enrichment of all RNAs, respectively).CC BY · PubMed Central
Figure 4 Combinatorial Interactions among RNA-Binding Proteins and mRNAs (A) The significance of the overlap between mRNA targets for each pair of RBPs (1% FDR threshold) is represented as a hierarchically clustered heat map in which the color intensity represents the negative log10 p-value, which was calculated using the hypergeometric density distribution and corrected for multiple hypothesis testing using the Bonferroni method. (B) An example of a cluster of functionally and cytotopically related mRNAs defined by their pattern of binding to multiple RBPs. The heat map represents RBPs (rows) and mRNAs (columns) color coded to reflect the certainty with which we infer that a specific mRNA is a target of a specific RBP (10% FDR [black] to 0% FDR [yellow]). These 78 mRNAs were associated (at a 1% FDR threshold) with at least four of a set of six RBPs (Ssd1, Khd1, Pub1, Ypl184c, Scp160, and Nab6) whose targets are enriched for mRNAs encoding proteins localized to the cell wall.
Figure 4 Combinatorial Interactions among RNA-Binding Proteins and mRNAs (A) The significance of the overlap between mRNA targets for each pair of RBPs (1% FDR threshold) is represented as a hierarchically clustered heat map in which the color intensity represents the negative log10 p-value, which was calculated using the hypergeometric density distribution and corrected for multiple hypothesis testing using the Bonferroni method. (B) An example of a cluster of functionally and cytotopically related mRNAs defined by their pattern of binding to multiple RBPs. The heat map represents RBPs (rows) and mRNAs (columns) color coded to reflect the certainty with which we infer that a specific mRNA is a target of a specific RBP (10% FDR [black] to 0% FDR [yellow]). These 78 mRNAs were associated (at a 1% FDR threshold) with at least four of a set of six RBPs (Ssd1, Khd1, Pub1, Ypl184c, Scp160, and Nab6) whose targets are enriched for mRNAs encoding proteins localized to the cell wall.CC BY · PubMed Central
Figure 5 Diverse Sequence Motifs Enriched in mRNAs Bound by Specific RNA-Binding Proteins A pictogram (http://genes.mit.edu/pictogram.html) represents the regular expression patterns defined for FIRE motifs or the preferred base composition of the position-specific scoring matrices for REFINE motifs. For each motif, the negative log10 p-value of the significance of genome-wide enrichment for motif sites in targets is represented (using a color scale) for segments of its mRNA targets (5′ = 200 bases upstream of start codon, CDS = protein coding sequence, 3′ = 200 bases downstream of stop codon). Arrows indicate motifs with a forward strand bias, i.e., the reverse complements of the motifs are not significantly enriched (p > 10−4 based on the hypergeometric distribution) in targets. “Cons” indicates the negative log10 p-value measuring whether motif sites in targets are more likely to be conserved in orthologous sequence alignments in S. bayanus than are motif sites occurring in nontargets, based on the hypergeometric distribution. Asterisks (*) denote motifs matching previously described RNA-binding elements (details in text). Exact data values and full descriptions of all motifs are presented in Table S4.
Figure 5 Diverse Sequence Motifs Enriched in mRNAs Bound by Specific RNA-Binding Proteins A pictogram (http://genes.mit.edu/pictogram.html) represents the regular expression patterns defined for FIRE motifs or the preferred base composition of the position-specific scoring matrices for REFINE motifs. For each motif, the negative log10 p-value of the significance of genome-wide enrichment for motif sites in targets is represented (using a color scale) for segments of its mRNA targets (5′ = 200 bases upstream of start codon, CDS = protein coding sequence, 3′ = 200 bases downstream of stop codon). Arrows indicate motifs with a forward strand bias, i.e., the reverse complements of the motifs are not significantly enriched (p > 10−4 based on the hypergeometric distribution) in targets. “Cons” indicates the negative log10 p-value measuring whether motif sites in targets are more likely to be conserved in orthologous sequence alignments in S. bayanus than are motif sites occurring in nontargets, based on the hypergeometric distribution. Asterisks (*) denote motifs matching previously described RNA-binding elements (details in text). Exact data values and full descriptions of all motifs are presented in Table S4.CC BY · PubMed Central
Figure 6 Diverse Combinatorial Patterns of RNA-Binding Protein Interactions with a Choice Sample of mRNAs (A–K) Putative binding sites of RBPs in target mRNAs. The relative lengths of the 5′-UTR, coding sequence, and 3′-UTR are drawn to scale. For mRNAs for which there are reliable measurements for untranslated sequence lengths (SUN4, DSE2, SCW4, CLN2, PUF2, PMA1, SUR7, and HHT1) [63], we added 50 bases onto the estimated 5′-UTR and 3′-UTR lengths, because the estimated UTR lengths are likely conservative. For mRNAs that do not have reliable untranslated region measurements (CTS1, EGT2, and MRP1), we used 250 bases upstream and downstream of the coding sequence as the 5′-UTR and 3′-UTR, respectively. The positions of the start and stop codons are indicated by stop signals. Putative binding sites for RBPs with strong evidence for association (1% FDR) are marked (Puf3-REFINE, Puf4-FIRE, Puf5-REFINE, Pub1-FIRE, Puf1/2-REFINE, Ssd1-REFINE, Nsr1-REFINE, Yll032c-REFINE, Pin4-REFINE, and Nrd1/Nab3-REFINE) (Figure 5 and Table S4). RBPs that we found to be associated with the mRNA, but for which the recognition elements are not yet known, are listed to the right of the mRNA. The number of Pab1 molecules shown bound to the poly(A) tail represents the degree of enrichment of the corresponding mRNA in the Pab1 IPs (log2 immunopurification enrichment −6 = 0, −5 = 1, etc.) and not the number of Pab1 molecules bound per mRNA. The cap-binding proteins, Cbc1/2 and eiF4e, are shown by default at the cap site.
Figure 6 Diverse Combinatorial Patterns of RNA-Binding Protein Interactions with a Choice Sample of mRNAs (A–K) Putative binding sites of RBPs in target mRNAs. The relative lengths of the 5′-UTR, coding sequence, and 3′-UTR are drawn to scale. For mRNAs for which there are reliable measurements for untranslated sequence lengths (SUN4, DSE2, SCW4, CLN2, PUF2, PMA1, SUR7, and HHT1) [63], we added 50 bases onto the estimated 5′-UTR and 3′-UTR lengths, because the estimated UTR lengths are likely conservative. For mRNAs that do not have reliable untranslated region measurements (CTS1, EGT2, and MRP1), we used 250 bases upstream and downstream of the coding sequence as the 5′-UTR and 3′-UTR, respectively. The positions of the start and stop codons are indicated by stop signals. Putative binding sites for RBPs with strong evidence for association (1% FDR) are marked (Puf3-REFINE, Puf4-FIRE, Puf5-REFINE, Pub1-FIRE, Puf1/2-REFINE, Ssd1-REFINE, Nsr1-REFINE, Yll032c-REFINE, Pin4-REFINE, and Nrd1/Nab3-REFINE) (Figure 5 and Table S4). RBPs that we found to be associated with the mRNA, but for which the recognition elements are not yet known, are listed to the right of the mRNA. The number of Pab1 molecules shown bound to the poly(A) tail represents the degree of enrichment of the corresponding mRNA in the Pab1 IPs (log2 immunopurification enrichment −6 = 0, −5 = 1, etc.) and not the number of Pab1 molecules bound per mRNA. The cap-binding proteins, Cbc1/2 and eiF4e, are shown by default at the cap site.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 163 references

Research works printed but not linked: 159

  1. Hieronymus, 2004, Genes Dev, 18, 2845
  2. Moore, 2005, Science, 309, 1514
  3. Halbeisen, 2008, Cell Mol Life Sci, 65, 798
  4. Keene, 2007, Nat Rev Genet, 8, 533
  5. Keene, 2002, Mol Cell, 9, 1161
  6. Birney, 2007, Nature, 447, 799
  7. Xie, 2005, Nature, 434, 338
  8. Kellis, 2003, Nature, 423, 241
  9. Blencowe, 2006, Cell, 126, 37
  10. Pleiss, 2007, Mol Cell, 27, 928
  11. Pleiss, 2007, PLoS Biol, 5
  12. Walter, 1994, Annu Rev Cell Biol, 10, 87
  13. Lecuyer, 2007, Cell, 131, 174
  14. Ghaemmaghami, 2003, Nature, 425, 737
  15. Lu, 2007, Nat Biotechnol, 25, 117
  16. Kuhn, 2001, Mol Cell Biol, 21, 916
  17. Newman, 2006, Nature, 441, 840
  18. Yang, 2003, Genome Res, 13, 1863
  19. Wang, 2002, Proc Natl Acad Sci U S A, 99, 5860
  20. Shock, 2007, Genome Biol, 8, R134
  21. Grigull, 2004, Mol Cell Biol, 24, 5534
  22. Dreyfuss, 1993, Annu Rev Biochem, 62, 289
  23. Maniatis, 2002, Nature, 416, 499
  24. Hieronymus, 2003, Nat Genet, 33, 155
  25. Kim Guisbert, 2005, RNA, 11, 383
  26. Gerber, 2004, PLoS Biol, 2, E79
  27. Brown, 2001, Cell, 107, 477
  28. Gerber, 2006, Proc Natl Acad Sci U S A, 103, 4487
  29. Gray, 1996, Proc Natl Acad Sci U S A, 93, 4925
  30. Lal, 2004, Embo J, 23, 3092
  31. Padmanabhan, 2006, Genes Dev, 20, 199
  32. Shepard, 2003, Proc Natl Acad Sci U S A, 100, 11429
  33. Sonoda, 1999, Genes Dev, 13, 2704
  34. Tenenbaum, 2000, Proc Natl Acad Sci U S A, 97, 14085
  35. Ule, 2005, Nat Genet, 37, 844
  36. Duttagupta, 2005, Mol Cell Biol, 25, 5499
  37. Inada, 2004, Proc Natl Acad Sci U S A, 101, 434
  38. Johansson, 2007, Proc Natl Acad Sci U S A, 104, 20872
  39. Beilharz, 2007, RNA, 13, 982
  40. Li, 2003, Nucleic Acids Res, 31, 1830
  41. Hodges, 1999, Nucleic Acids Res, 27, 69
  42. Guldener, 2005, Nucleic Acids Res, 33, D364
  43. Rigaut, 1999, Nat Biotechnol, 17, 1030
  44. Tusher, 2001, Proc Natl Acad Sci U S A, 98, 5116
  45. Efron, 2002, Genet Epidemiol, 23, 70
  46. Bonafe, 2005, Cancer Res, 65, 3762
  47. Hentze, 1991, Nucleic Acids Res, 19, 1739
  48. Gangloff, 1990, Mol Cell Biol, 10, 3551
  49. Chen, 2005, Science, 307, 714
  50. Lang, 2001, Nucleic Acids Res, 29, 2567
  51. Conrad, 2000, Genetics, 154, 557
  52. Chu, 1998, Science, 282, 699
  53. DeRisi, 1997, Science, 278, 680
  54. Harbison, 2004, Nature, 431, 99
  55. Hinnebusch, 1985, Mol Cell Biol, 5, 2349
  56. Lee, 2002, Science, 298, 799
  57. Lieb, 2001, Nat Genet, 28, 327
  58. Spellman, 1998, Mol Biol Cell, 9, 3273
  59. Xie, 2001, Proc Natl Acad Sci U S A, 98, 3056
  60. Zhu, 2000, Nature, 406, 90
  61. Ashburner, 2000, Nat Genet, 25, 25
  62. Arava, 2003, Proc Natl Acad Sci U S A, 100, 3889
  63. David, 2006, Proc Natl Acad Sci U S A, 103, 5320
  64. Sachs, 1986, Cell, 45, 827
  65. Kessler, 1998, Mol Cell Biol, 18, 51
  66. Preiss, 1998, RNA, 4, 1321
  67. Irie, 2002, Embo J, 21, 1158
  68. Gao, 2005, Proc Natl Acad Sci U S A, 102, 4258
  69. Lewis, 1996, Nucleic Acids Res, 24, 3332
  70. Tardiff, 2006, Mol Cell, 24, 917
  71. Collins, 2007, Mol Cell Proteomics, 6, 439
  72. Vasiljeva, 2006, Mol Cell, 21, 239
  73. Moriya, 1999, Yeast, 15, 481
  74. Kaeberlein, 2002, Genetics, 160, 83
  75. Gari, 2001, Genes Dev, 15, 2803
  76. Nash, 2001, Genetics, 157, 1469
  77. Lee, 1993, J Biol Chem, 268, 15080
  78. Fujita, 1989, Gene, 85, 321
  79. de Bruin, 2006, Mol Cell, 23, 483
  80. Loy, 1999, Mol Cell Biol, 19, 3312
  81. Pramila, 2002, Genes Dev, 16, 3034
  82. Verna, 1997, Proc Natl Acad Sci U S A, 94, 13804
  83. O'Rourke, 2002, Mol Cell Biol, 22, 4739
  84. Brown, 1997, Genes Dev, 11, 2972
  85. Michaelis, 1988, Mol Cell Biol, 8, 1309
  86. Grishin, 1998, Genetics, 149, 879
  87. Raitt, 2000, Mol Biol Cell, 11, 2335
  88. Wittenberg, 1990, Cell, 62, 225
  89. Elemento, 2007, Mol Cell, 28, 337
  90. Bailey, 1994, Proc Int Conf Intell Syst Mol Biol, 2, 28
  91. Steinmetz, 1998, Proc Natl Acad Sci U S A, 95, 6699
  92. Carroll, 2004, Mol Cell Biol, 24, 6241
  93. Steinmetz, 2001, Nature, 413, 327
  94. Nagalakshmi, 2008, Science, 320, 1344
  95. Aviv, 2003, Nat Struct Biol, 10, 614
  96. Aviv, 2006, Nat Struct Mol Biol, 13, 168
  97. Berger, 2006, Nat Biotech, 24, 1429
  98. Ule, 2003, Science, 302, 1212
  99. Uesono, 1997, J Biol Chem, 272, 16103
  100. Ibeas, 2001, Plant J, 25, 271
  101. Kaeberlein, 2004, Genetics, 166, 1661
  102. Reinke, 2004, J Biol Chem, 279, 14752
  103. Wheeler, 2003, Proc Natl Acad Sci U S A, 100, 2766
  104. Costigan, 1992, Mol Cell Biol, 12, 1162
  105. Kurischko, 2005, Genetics, 171, 443
  106. Phatnani, 2004, Biochemistry, 43, 15702
  107. Mewes, 2006, Nucleic Acids Res, 34, D169
  108. Beltzer, 1986, J Biol Chem, 261, 5160
  109. Delbecq, 1994, Mol Cell Biol, 14, 2378
  110. di Blasi, 1993, Yeast, 9, 21
  111. Hinnebusch, 1984, Proc Natl Acad Sci U S A, 81, 6442
  112. Kebaara, 2003, Nucleic Acids Res, 31, 3157
  113. Krummeck, 1991, Curr Genet, 20, 465
  114. Strick, 1987, Mol Cell Biol, 7, 2728
  115. Vilela, 1998, Nucleic Acids Res, 26, 1150
  116. Sachs, 2006, Genes Dev, 20, 915
  117. Gilbert, 2007, Science, 317, 1224
  118. Iizuka, 1994, Mol Cell Biol, 14, 7322
  119. Spriggs, 2008, Biol Cell, 100, 27
  120. Cox, 1996, Cell, 87, 391
  121. Rüegsegger, 2001, Cell, 107, 103
  122. Czaplinski, 2006, Trends Biochem Sci, 31, 687
  123. Groisman, 2000, Cell, 103, 435
  124. Huang, 2004, Curr Opin Cell Biol, 16, 308
  125. Kosik, 2002, Sci STKE, 2002, PE16
  126. Lambert, 2002, Nature, 420, 682
  127. Martin, 2004, Curr Opin Neurobiol, 14, 305
  128. Parker, 2007, Mol Cell, 25, 635
  129. Smith, 2004, Neuroscientist, 10, 495
  130. St Johnston, 2005, Nat Rev Mol Cell Biol, 6, 363
  131. Sylvestre, 2003, Genome Biol, 4, R44
  132. Aronov, 2007, Mol Cell Biol, 27, 3441
  133. Gerst, 2008, Trends Cell Biol, 18, 68
  134. Long, 1997, Science, 277, 383
  135. Takizawa, 1997, Nature, 389, 90
  136. Takizawa, 2000, Proc Natl Acad Sci U S A, 97, 5273
  137. Olivier, 2005, Mol Cell Biol, 25, 4752
  138. Jambhekar, 2005, Proc Natl Acad Sci U S A, 102, 18005
  139. Hurt, 2004, Proc Natl Acad Sci U S A, 101, 1858
  140. Ciesla, 2006, Acta Biochim Pol, 53, 11
  141. Fleischer, 2006, Genes Dev, 20, 1294
  142. Lee, 2006, Nucleic Acids Res, 34, 5705
  143. Rother, 2007, Genes Dev, 21, 1409
  144. Shetty, 2007, Mol Cell Biol, 27, 5607
  145. Finn, 2006, Nucleic Acids Res, 34, D247
  146. Hurowitz, 2003, Genome Biol, 5, R2
  147. de Hoog, 2004, Cell, 117, 649
  148. Mili, 2008, Nature, 453, 115
  149. Rodriguez, 2008, Curr Opin Cell Biol, 20, 144
  150. Willis, 2007, J Cell Biol, 178, 965
  151. Kapust, 2001, Protein Eng, 14, 993
  152. Branham, 2007, BMC Biotechnol, 7, 8
  153. Fare, 2003, Anal Chem, 75, 4672
  154. Demeter, 2007, Nucleic Acids Res, 35, D766
  155. Eisen, 1998, Proc Natl Acad Sci U S A, 95, 14863
  156. Saldanha, 2004, Bioinformatics, 20, 3246
  157. Boyle, 2004, Bioinformatics, 20, 3710
  158. Gish, 1993, Nat Genet, 3, 266
  159. Sheather, 1991, J R Stat Soc B, 53, 683

Cited by

Metadata

Authors
Hogan, D. J., Riordan, D. P., Gerber, A. P., Herschlag, D., & Brown, P. O.
Affiliations
  • Howard Hughes Medical Institute (US)
  • ETH Zurich (CH)
  • Stanford Medicine (US)
Corresponding author
  • Gerber, André P
  • Herschlag, Daniel
  • Brown, Patrick O
Venue
PLoS Biology
Published
2008-10-28
Volume
6
Issue
10
Pages
e255
ISSN
  • 1544-9173 (ISSN-L)
  • 1545-7885
OpenAlex
W2149480306
Cited by
609
References
164
Citations by year
2026: 8 · 2025: 13 · 2024: 33 · 2023: 27 · 2022: 19 · 2021: 32 · 2020: 21 · 2019: 38 · 2018: 27 · 2017: 34 · 2016: 34 · 2015: 37 · 2014: 64 · 2013: 56 · 2012: 49
FWCI
16.06
Type
journal article
Language
en
Open access
Locations
  • PLoS Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Repository for Publications and Research Data (ETH Zurich) (publishedVersion, cc-by)
  • Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • ETH Zürich Research Collection (cc-by)
Funders
  • National Science Foundation
  • Howard Hughes Medical Institute
  • American Heart Association
  • National Human Genome Research Institute (T32HG00044, T32HG000044)
  • National Cancer Institute (CA 77097, R01CA77097, R01 CA77097-08, R01CA077097)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords
RNA-binding proteins, post-transcriptional regulation, Saccharomyces cerevisiae, 3' untranslated region, 5' untranslated region, RNA-protein interactions, combinatorial regulation, mRNA transcriptome
MeSH terms
Protein Binding, RNA, Messenger, Signal Transduction, RNA-Binding Proteins, Oligonucleotide Array Sequence Analysis, Untranslated Regions, Saccharomyces cerevisiae Proteins, Databases, Protein, Protein Interaction Domains and Motifs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.